Literature DB >> 26189527

A case of primary biliary cirrhosis that complicated with combined hepatocellular and cholangiocellular carcinoma.

Masakazu Kobayashi1, Kiyoshi Furuta2, Hiroshi Kitamura3, Kazuhiro Oguchi4, Masayuki Arai3, Shoichiro Koike3, Koh Nakazawa5.   

Abstract

Primary biliary cirrhosis (PBC) is frequently complicated with hepatocellular carcinoma (HCC), but complication with combined hepatocellular and cholangiocellular carcinoma (cHCC-CC) or cholangiocellular carcinoma (CCC) has not been reported. Here, we describe a case of PBC in which cHCC-CC occurred. The patient was a 70-year-old man who had developed jaundice at 62 years old. He was diagnosed with PBC based on a liver biopsy and blood tests. In August 2006, blood tests showed elevated alpha-fetoprotein, and a liver tumor in the right lobe and a metastatic lymphadenopathy in the back near to the head of the pancreas were detected by abdominal contrast-enhanced CT. A (18)F-fluorodeoxyglucose-PET scan showed accumulation of the tracer in the tumor and in a lymph node at the back of the pancreas. The tumor and lymph node were removed, and the tumor was diagnosed pathologically as cHCC-CC based on the presence of features of HCC and CCC. This case is the first to show that a patient with PBC can develop cHCC-CC. This is of interest, since cHCC-CC may originate in hepatic stem cells or hepatic precursor cells. This case also suggests that cHCC-CC should be included as a differential diagnosis for a liver tumor complicated with PBC.

Entities:  

Keywords:  Hepatic stem cell; Liver tumor; Primary biliary cirrhosis; cHCC-CC

Year:  2011        PMID: 26189527     DOI: 10.1007/s12328-011-0223-z

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  22 in total

1.  Immunohistochemical evidence for hepatic progenitor cells in liver diseases.

Authors:  Jianyou Tan; Prodromos Hytiroglou; Rosemary Wieczorek; Young NyuN Park; Swan N Thung; Byron Arias; Neil D Theise
Journal:  Liver       Date:  2002-10

2.  Oval cell hyperplasia in asparaginase--induced liver damage.

Authors:  E Zuckerman; I Misselevich; J H Boss
Journal:  Liver       Date:  2002-08

3.  Combined liver cell and bile duct carcinoma.

Authors:  R A ALLEN; J R LISA
Journal:  Am J Pathol       Date:  1949-07       Impact factor: 4.307

4.  Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.

Authors:  Mina Komuta; Bart Spee; Sara Vander Borght; Rita De Vos; Chris Verslype; Raymond Aerts; Hirohisa Yano; Tetsuya Suzuki; Masanori Matsuda; Hideki Fujii; Valeer J Desmet; Masamichi Kojiro; Tania Roskams
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

5.  Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.

Authors:  Sakae Nagaoka; Satoshi Itano; Masatoshi Ishibashi; Takuji Torimura; Kenkichi Baba; Junji Akiyoshi; Junichi Kurogi; Satoru Matsugaki; Kinya Inoue; Nobuyoshi Tajiri; Akio Takada; Eiji Ando; Ryoko Kuromatsu; Hayato Kaida; Mina Kurogi; Hironori Koga; Ryukichi Kumashiro; Naofumi Hayabuchi; Masamichi Kojiro; Michio Sata
Journal:  Liver Int       Date:  2006-09       Impact factor: 5.828

6.  Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.

Authors:  E J Heathcote
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

7.  Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma.

Authors:  Satoshi Yamamoto; Shoji Kubo; Seikan Hai; Takahiro Uenishi; Takatsugu Yamamoto; Taichi Shuto; Shigekazu Takemura; Hiromu Tanaka; Osamu Yamazaki; Kazuhiro Hirohashi; Takashi Tanaka
Journal:  Cancer Sci       Date:  2004-07       Impact factor: 6.716

8.  Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma.

Authors:  S Nakamura; S Suzuki; T Sakaguchi; A Serizawa; H Konno; S Baba; S Baba; H Muro
Journal:  Cancer       Date:  1996-10-15       Impact factor: 6.860

9.  Hepatic 'stem cell' malignancies in adults: four cases.

Authors:  N D Theise; J L Yao; K Harada; P Hytiroglou; B Portmann; S N Thung; W Tsui; H Ohta; Y Nakanuma
Journal:  Histopathology       Date:  2003-09       Impact factor: 5.087

10.  Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.

Authors:  Yan-Ming Zhou; Jia-Mei Yang; Bin Wang; Feng Xu; Ying Tong; Dian-Qi Li
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-12
View more
  2 in total

1.  Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma.

Authors:  Ryuta Ide; Akihiko Oshita; Takashi Nishisaka; Hideki Nakahara; Shiomi Aimitsu; Toshiyuki Itamoto
Journal:  World J Hepatol       Date:  2017-12-28

Review 2.  Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development.

Authors:  Aleksandar Arsenijevic; Bojana Stojanovic; Jelena Milovanovic; Dragana Arsenijevic; Nebojsa Arsenijevic; Marija Milovanovic
Journal:  Int J Mol Sci       Date:  2020-07-19       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.